GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IGC Pharma IGC · USD

Industrials · US listing · 🇺🇸 United States

Compare

0.20

+2.20%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on IGC Pharma

Our reporting

We have not reported on IGC Pharma yet.

Next results

13 Nov 2026

Due on 13 Nov 2026. Analysts expect earnings of -0.02 a share.

Past results

Reported against what analysts expected

14 Aug 202615 May 202620 Mar 202614 Nov 202519 Aug 202530 Jun 2025
Earnings per share-0.03-0.02-0.02-0.02-0.02-0.02
Forecast-0.02-0.02-0.02-0.02-0.03-0.02
Revenue$265,000$317,000$246,500$191,000$328,000$260,000
Forecast$164,000$198,000$250,000$383,000$326,000$305,000

Key events

  1. 19 Apr 201310-to-1 reverse split
  2. 13 Apr 2006Listed

IGC Pharma in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.